Form 4 Tracker
Julie Rubinstein

President and COO · 15 filings · Latest: Apr 27, 2026

Adaptive Biotechnologies Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ADPT
Julie RubinsteinPresident and COOApr 13, 2026
Sale
$13.1519,060$250.6K421,174
ADPT
Julie RubinsteinPresident and COOApr 13, 2026
Option Exercise
$7.8014,722$114.9K440,234
ADPT
Julie RubinsteinPresident and COOApr 10, 2026
Sale
$12.7719,060$243.3K425,512
ADPT
Julie RubinsteinPresident and COOApr 10, 2026
Option Exercise
$7.2714,722$107.0K444,572
ADPT
Julie RubinsteinPresident and COOApr 9, 2026
Sale
$13.8619,060$264.2K429,850
ADPT
Julie RubinsteinPresident and COOApr 9, 2026
Option Exercise
$7.2714,722$107.0K448,910
ADPT
Julie RubinsteinPresident and COOApr 8, 2026
Sale
$14.8330,941$458.9K434,188
ADPT
Julie RubinsteinPresident and COOApr 8, 2026
Option Exercise
$9.4426,603$251.3K465,129
ADPT
Julie RubinsteinPresident and COOApr 7, 2026
Sale
$13.5619,060$258.5K438,526
ADPT
Julie RubinsteinPresident and COOApr 7, 2026
Option Exercise
$7.2714,722$107.0K457,586
ADPT
Julie RubinsteinPresident and COOApr 6, 2026
Sale
$14.3319,060$273.1K442,864
ADPT
Julie RubinsteinPresident and COOApr 6, 2026
Option Exercise
$7.2714,722$107.0K461,924
ADPT
Julie RubinsteinPresident and COOApr 2, 2026
Sale
$14.6019,060$278.3K447,202
ADPT
Julie RubinsteinPresident and COOApr 2, 2026
Option Exercise
$7.2714,722$107.0K466,262
ADPT
Julie RubinsteinPresident and COOApr 1, 2026
Sale
$14.4519,060$275.4K451,540
ADPT
Julie RubinsteinPresident and COOApr 1, 2026
Option Exercise
$7.2714,722$107.0K470,600
ADPT
Julie RubinsteinPresident and COOMar 31, 2026
Sale
$13.4519,060$256.4K455,878
ADPT
Julie RubinsteinPresident and COOMar 31, 2026
Option Exercise
$7.2714,722$107.0K474,938
ADPT
Julie RubinsteinPresident and COOMar 30, 2026
Sale
$12.6319,060$240.7K460,216
ADPT
Julie RubinsteinPresident and COOMar 30, 2026
Option Exercise
$7.2714,722$107.0K479,276